Memorial Şişli Hospital
| Turkey | Thailand | South Korea | |
| Chemotherapy for breast cancer | from AUD $1,688 | from AUD $4,220 | from AUD $27,010 |
| Removal of rhabdomyosarcoma | from AUD $21,102 | from AUD $39,390 | - |
| Radiation therapy for colorectal cancer | from AUD $9,847 | from AUD $7,737 | - |
| Radiation Therapy for Sarcomas | from AUD $4,572 | from AUD $9,847 | - |
| Complex treatment of rhabdomyosarcoma | from AUD $63,305 | - | - |
Associate Professor Muhammet Derda Ozer is a specialist in ocular oncology with 25,000+ procedures performed at Istanbul Yeni Yuzyil University.
Professor Bozkurt is a leading paediatric haematologist-oncologist who trained at Harvard University and Cincinnati Children's Hospital in the USA.
Professor Yesim Yildirim is a leading medical oncologist at the JCI-accredited Anadolu Medical Center, specialising in targeted therapies and immunotherapy for complex tumours.
Diagnosis in Turkey follows a fast-track multidisciplinary protocol to confirm rhabdomyosarcoma subtypes and staging. Within 48 to 72 hours, specialists use PET-CT, 3 Tesla MRI, and molecular pathology. They map tumours to ensure a precise, risk-stratified treatment plan before any therapy begins.
Bookimed Expert Insight: Turkish oncology centres like Anadolu Medical Center and Memorial Şişli serve patients from over 160 countries. They have refined the intake process into a 3-day window. This speed is critical for rhabdomyosarcoma. It allows intensive treatment to start before the tumour can spread further.
Patient Consensus: Patients in Turkey should prepare for a busy first week. This week typically involves repeat imaging, bone marrow biopsies, and port placement. Bringing original pathology slides is essential. This avoids delays while the tumour board reviews the case.
International families choose Turkey for rhabdomyosarcoma due to JCI-accredited infrastructure and rapid access to multidisciplinary tumour boards. Leading Istanbul centres combine paediatric oncology, surgery, and advanced radiotherapy. Specialists use TrueBeam STx and MR-LINAC technology to target aggressive soft tissue sarcomas with extreme precision.
Bookimed Expert Insight: Turkish oncology centres like Memorial Şişli and Anadolu Medical Center bridge the gap for Australian patients by following American Johns Hopkins protocols or NCCN guidelines. This means treatment for rare sarcomas aligns with Western standards. Choosing Istanbul often secures access to specialised multidisciplinary teams within days rather than the weeks required in public systems.
Patient Consensus: Patients value the convenience of having diagnostic imaging, second opinions, and intensive treatment scheduled immediately upon arrival in Turkey. The combination of JCI-accredited care and dedicated English-speaking interpreters provides a necessary sense of security for families managing complex childhood cancers.
Leading Turkish oncology centres for sarcoma and rhabdomyosarcoma care include Anadolu Medical Center, Memorial Healthcare Group, and Hisar Hospital Intercontinental. These JCI-accredited facilities use TrueBeam STx radiation, multidisciplinary tumour boards, and complex surgical resection. They treat rare paediatric and adult malignancies.
Bookimed Expert Insight: While many centres offer radiotherapy, clinics like Memorial Bahçelievler use Elekta Versa HD technology. This system adapts to a patient's breathing during treatment. It reduces procedure time by two-thirds. This is vital for paediatric rhabdomyosarcoma patients who struggle to stay still.
Patient Consensus: Patients note large private healthcare groups in Istanbul provide the most streamlined care for complex sarcomas. They suggest looking for facilities with dedicated paediatric oncology wards. Children then receive specialised support during treatment in Turkey.
Turkish clinics treat rhabdomyosarcoma using a multidisciplinary approach combining surgery, multi-agent chemotherapy, and precision radiotherapy. Specialists follow international ESMO and NCCN guidelines. An example is Prof. Dr Yesim Yildirim at Anadolu Medical Center. Treatment typically involves systemic therapy, surgical resection, and radiation technologies like MR-LINAC.
Bookimed Expert Insight: Turkish oncology centres often provide access to intensive cellular therapies. These are rarely associated with sarcoma care elsewhere. For example, Medical Park Bahcelievler performs many stem cell transplants and CAR T-cell therapies. This allows specialists to manage the haematological recovery that follows aggressive chemotherapy for rhabdomyosarcoma.
Patient Consensus: Patients in Turkey note that treatment plans are highly personalised. These plans are based on tumour location and pathology results. Experience with paediatric oncology protocols is considered vital. This is especially true when combining surgery with radiation for localised disease.
Turkish oncology centres provide robotic surgery for rhabdomyosarcoma using da Vinci XI systems. High-precision radiotherapy like MR-LINAC and TrueBeam STx is widely available. Dedicated proton therapy is highly specialised. Patients should confirm current gantry status or local equivalents like MR-LINAC before booking.
Bookimed Expert Insight: While proton therapy is a common request, Turkish centres often use MR-LINAC as a precise alternative. Hisar Hospital Intercontinental and Memorial Göztepe Hospital both have this technology. It allows doctors to see tumours in real-time during radiation. This provides the high level of accuracy needed for sensitive areas like the head or neck.
Patient Consensus: Patients note that major Turkish cities offer accessible private oncology care and expert second opinions. They emphasise confirming clinic experience with specific tumour sites, such as orbital or pelvic disease. This should happen during the planning stage.